40 Chapter 2 Table 1. Continued Author Year Country Study design Number of patients* Number of studies Aim of the study Type of resections included Shigeta et al. 92 2016 Japan SR and MA 909 4 To evaluate the usefulness of a TDT for the prevention of AL after an AR for rectal cancer. AR Singh et al. 93 2014 New Zealand SR and MA 2483 7 To evaluate the predictive value of CRP in this setting. All types of colorectal procedures Škrabec et al. 94 2022 Spain SR N/A 9 To review and to assess the quality of the scientific articles regarding early and late AL after CRC surgery and their risk factors. All types of colorectal procedures Snijders et al. 95 2012 The Netherlands MA 10343 22 To compare AL-related mortality in comparison to overall postoperative mortality after LAR for rectal cancer. LAR Su’a et al. 96 2017 New Zealand SR 8988 36 To assess biomarkers as potential diagnostic tests for preclinical detection of AL. All types of colorectal procedures Su’a et al. 97 2020 New Zealand MA 1639 8 To evaluate the accuracy of procalcitonin in the early diagnosis of AL following CRC surgery. All types of colorectal procedures Tamura et al. 98 2021 Japan RCT 161 N/A To assess the incidence of AL in patients with rectal cancer after laparoscopic AR with or without TDT on the hypothesis that it could contribute to prevent AL without reference to diverting stoma. LAR Tan et al. 99 2009 Singapore MA 11429 25 To evaluate the need for routine stoma formation. LAR Tocchi et al. 100 2000 Italy RCT 112 N/A To investigate the role of omentoplasty, by means of intact omentum, in preventing AL after rectal resection. AR
RkJQdWJsaXNoZXIy MTk4NDMw